184 related articles for article (PubMed ID: 29222138)
1. Application of Large-Scale Aptamer-Based Proteomic Profiling to Planned Myocardial Infarctions.
Jacob J; Ngo D; Finkel N; Pitts R; Gleim S; Benson MD; Keyes MJ; Farrell LA; Morgan T; Jennings LL; Gerszten RE
Circulation; 2018 Mar; 137(12):1270-1277. PubMed ID: 29222138
[TBL] [Abstract][Full Text] [Related]
2. Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease.
Ngo D; Sinha S; Shen D; Kuhn EW; Keyes MJ; Shi X; Benson MD; O'Sullivan JF; Keshishian H; Farrell LA; Fifer MA; Vasan RS; Sabatine MS; Larson MG; Carr SA; Wang TJ; Gerszten RE
Circulation; 2016 Jul; 134(4):270-85. PubMed ID: 27444932
[TBL] [Abstract][Full Text] [Related]
3. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
Smith JG; Gerszten RE
Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
[TBL] [Abstract][Full Text] [Related]
4. Multiplexed, Quantitative Workflow for Sensitive Biomarker Discovery in Plasma Yields Novel Candidates for Early Myocardial Injury.
Keshishian H; Burgess MW; Gillette MA; Mertins P; Clauser KR; Mani DR; Kuhn EW; Farrell LA; Gerszten RE; Carr SA
Mol Cell Proteomics; 2015 Sep; 14(9):2375-93. PubMed ID: 25724909
[TBL] [Abstract][Full Text] [Related]
5. Novel Insights Into the Effects of Interleukin 6 Antagonism in Non-ST-Segment-Elevation Myocardial Infarction Employing the SOMAscan Proteomics Platform.
George MJ; Kleveland O; Garcia-Hernandez J; Palmen J; Lovering R; Wiseth R; Aukrust P; Engmann J; Damås JK; Hingorani AD; Gullestad L; Casas JP; Ueland T
J Am Heart Assoc; 2020 Jun; 9(12):e015628. PubMed ID: 32515246
[TBL] [Abstract][Full Text] [Related]
6. Aptamer-Based Proteomic Platform Identifies Novel Protein Predictors of Incident Heart Failure and Echocardiographic Traits.
Nayor M; Short MI; Rasheed H; Lin H; Jonasson C; Yang Q; Hveem K; Felix JF; Morrison AC; Wild PS; Morley MP; Cappola TP; Benson MD; ; ; Ngo D; Sinha S; Keyes MJ; Shen D; Wang TJ; Larson MG; Brumpton BM; Gerszten RE; Omland T; Vasan RS
Circ Heart Fail; 2020 May; 13(5):e006749. PubMed ID: 32408813
[TBL] [Abstract][Full Text] [Related]
7. High-throughput targeted proteomics discovery approach and spontaneous reperfusion in ST-segment elevation myocardial infarction.
Shavadia JS; Granger CB; Alemayehu W; Westerhout CM; Povsic TJ; Brener SJ; van Diepen S; Defilippi C; Armstrong PW
Am Heart J; 2020 Feb; 220():137-144. PubMed ID: 31812755
[TBL] [Abstract][Full Text] [Related]
8. Proteomic Discovery and Validation of the Confounding Effect of Heparin Administration on the Analysis of Candidate Cardiovascular Biomarkers.
Beck HC; Jensen LO; Gils C; Ilondo AMM; Frydland M; Hassager C; Møller-Helgestad OK; Møller JE; Rasmussen LM
Clin Chem; 2018 Oct; 64(10):1474-1484. PubMed ID: 30115630
[TBL] [Abstract][Full Text] [Related]
9. Aptamer-based multiplexed proteomic technology for biomarker discovery.
Gold L; Ayers D; Bertino J; Bock C; Bock A; Brody EN; Carter J; Dalby AB; Eaton BE; Fitzwater T; Flather D; Forbes A; Foreman T; Fowler C; Gawande B; Goss M; Gunn M; Gupta S; Halladay D; Heil J; Heilig J; Hicke B; Husar G; Janjic N; Jarvis T; Jennings S; Katilius E; Keeney TR; Kim N; Koch TH; Kraemer S; Kroiss L; Le N; Levine D; Lindsey W; Lollo B; Mayfield W; Mehan M; Mehler R; Nelson SK; Nelson M; Nieuwlandt D; Nikrad M; Ochsner U; Ostroff RM; Otis M; Parker T; Pietrasiewicz S; Resnicow DI; Rohloff J; Sanders G; Sattin S; Schneider D; Singer B; Stanton M; Sterkel A; Stewart A; Stratford S; Vaught JD; Vrkljan M; Walker JJ; Watrobka M; Waugh S; Weiss A; Wilcox SK; Wolfson A; Wolk SK; Zhang C; Zichi D
PLoS One; 2010 Dec; 5(12):e15004. PubMed ID: 21165148
[TBL] [Abstract][Full Text] [Related]
10. Application of Proteomics Profiling for Biomarker Discovery in Hypertrophic Cardiomyopathy.
Shimada YJ; Hasegawa K; Kochav SM; Mohajer P; Jung J; Maurer MS; Reilly MP; Fifer MA
J Cardiovasc Transl Res; 2019 Dec; 12(6):569-579. PubMed ID: 31278493
[TBL] [Abstract][Full Text] [Related]
11. Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury.
Lewis GD; Wei R; Liu E; Yang E; Shi X; Martinovic M; Farrell L; Asnani A; Cyrille M; Ramanathan A; Shaham O; Berriz G; Lowry PA; Palacios IF; Taşan M; Roth FP; Min J; Baumgartner C; Keshishian H; Addona T; Mootha VK; Rosenzweig A; Carr SA; Fifer MA; Sabatine MS; Gerszten RE
J Clin Invest; 2008 Oct; 118(10):3503-12. PubMed ID: 18769631
[TBL] [Abstract][Full Text] [Related]
12. A new data mining approach for profiling and categorizing kinetic patterns of metabolic biomarkers after myocardial injury.
Baumgartner C; Lewis GD; Netzer M; Pfeifer B; Gerszten RE
Bioinformatics; 2010 Jul; 26(14):1745-51. PubMed ID: 20483816
[TBL] [Abstract][Full Text] [Related]
13. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.
Lin L; Zheng J; Yu Q; Chen W; Xing J; Chen C; Tian R
J Proteomics; 2018 Mar; 174():9-16. PubMed ID: 29278786
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic Profiling in Acute ST-Segment-Elevation Myocardial Infarction Identifies Succinate as an Early Marker of Human Ischemia-Reperfusion Injury.
Kohlhauer M; Dawkins S; Costa ASH; Lee R; Young T; Pell VR; Choudhury RP; Banning AP; Kharbanda RK; ; Saeb-Parsy K; Murphy MP; Frezza C; Krieg T; Channon KM
J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29626151
[TBL] [Abstract][Full Text] [Related]
15. Reference Values and Release Kinetics of B-Type Natriuretic Peptide Signal Peptide in Patients with Acute Myocardial Infarction.
Liebetrau C; Gaede L; Dörr O; Blumenstein J; Rosenburg S; Hoffmann J; Troidl C; Hamm CW; Nef HM; Möllmann H; Richards AM; Pemberton CJ
Clin Chem; 2015 Dec; 61(12):1532-9. PubMed ID: 26506995
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Multiplex Biomarker Panel for Hypertrophic Cardiomyopathy Using Quantitative Proteomics and Machine Learning.
Captur G; Heywood WE; Coats C; Rosmini S; Patel V; Lopes LR; Collis R; Patel N; Syrris P; Bassett P; O'Brien B; Moon JC; Elliott PM; Mills K
Mol Cell Proteomics; 2020 Jan; 19(1):114-127. PubMed ID: 31243064
[TBL] [Abstract][Full Text] [Related]
17. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-221 is a potential biomarker of myocardial hypertrophy and fibrosis in hypertrophic obstructive cardiomyopathy.
Huang D; Chen Z; Wang J; Chen Y; Liu D; Lin K
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31868204
[TBL] [Abstract][Full Text] [Related]
19. Proteomic Analysis of the Myocardium in Hypertrophic Obstructive Cardiomyopathy.
Coats CJ; Heywood WE; Virasami A; Ashrafi N; Syrris P; Dos Remedios C; Treibel TA; Moon JC; Lopes LR; McGregor CGA; Ashworth M; Sebire NJ; McKenna WJ; Mills K; Elliott PM
Circ Genom Precis Med; 2018 Dec; 11(12):e001974. PubMed ID: 30562113
[TBL] [Abstract][Full Text] [Related]
20. Proteomic signatures predict preeclampsia in individual cohorts but not across cohorts - implications for clinical biomarker studies.
Ghaemi MS; Tarca AL; Romero R; Stanley N; Fallahzadeh R; Tanada A; Culos A; Ando K; Han X; Blumenfeld YJ; Druzin ML; El-Sayed YY; Gibbs RS; Winn VD; Contrepois K; Ling XB; Wong RJ; Shaw GM; Stevenson DK; Gaudilliere B; Aghaeepour N; Angst MS
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5621-5628. PubMed ID: 33653202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
